Inherited warfarin resistance in Indian patients: does it occur?
Sharma
Vineeta
V
Biswas
Arijit
A
Saxena
Renu
R
D000925:Anticoagulants / Q000008:administration & dosage*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D065637:Cytochrome P-450 CYP2A6; D065729:Cytochrome P-450 CYP2C9; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D007194:India; D019934:International Normalized Ratio; D006899:Mixed Function Oxygenases / Q000235:genetics; D014675:Vegetables; D020246:Venous Thrombosis / Q000188:drug therapy*; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin / Q000008:administration & dosage*; D044465:White People / Q000235:genetics
D000925:Anticoagulants; D014859:Warfarin; D006899:Mixed Function Oxygenases; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D065637:Cytochrome P-450 CYP2A6; D064417:Vitamin K Epoxide Reductases